Jefferies raised its price target on The Medicines Company (NASDAQ: MDCO) from $36 to $38.50 following Q1 results with strong ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE